Research & Development (R&D)

Ranbaxy’s fight over generics with US FDA fails to block rivals

New Delhi, November 2014 – Ranbaxy filed lawsuit against USFDA on 11 Nov 2014 in the District of Columbia in…

10 years ago

Genzyme’s Lemtrada Approved by the FDA

New Delhi, November 18, 2014 – Genzyme, a Sanofi company, announced that the U.S. Food and Drug Administration (FDA) has…

10 years ago

US FDA withdraws approval for 2 Ranbaxy generic drugs

New Delhi, November 2014 – The US Food and Drug Administration has rescinded approvals given to Ranbaxy Laboratories for two…

10 years ago

Norms on conditions to delay and deny drug inspection issued by USFDA

New Delhi, November 2014 – A guidance has been issued by US FDA to pharma and biotech industry on the…

10 years ago

Sanofi India to sell Mumbai office space for Rs. 134 cr

Mumbai, Nov 12, 2014 – Sanofi India said its board of directors has approved selling its commercial space of five floors…

10 years ago

Decontrolling drug prices: SC refuses to interfere

New Delhi, October 2014 – The Supreme Court on Monday refused to interfere with the Centre’s decision to decontrol prices…

10 years ago

Strides clarifies on FDA alert

Bangalore, October 07, 2014 – Strides Arcolab has clarified that it has no role in distributing certain products manufactured by its…

10 years ago

Sun Pharma’s troubles with USFDA procedural: Credit Suisse

Halol plant has got 23 regulatory observations, but chances of import alert are low Mumbai, September 29, 2014 –  Sun…

10 years ago

Health Canada asks Ipca to stop ingredients shipment

USFDA detected data manipulation by the company Mumbai, September 24, 2014 – Just months after Ipca voluntarily stopped the export…

10 years ago

Superba(TM) Krill Oil Receives Regulatory Approval in India

New Delhi, September 10, 2014 – Aker BioMarine Antarctic AS, a customer-driven supplier of krill-derived phospholipid omega-3 products, has received…

10 years ago